{"id":14482,"date":"2022-06-10T17:55:00","date_gmt":"2022-06-10T21:55:00","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/actualites\/toutes-les-nouvelles\/"},"modified":"2022-06-30T17:58:08","modified_gmt":"2022-06-30T21:58:08","slug":"research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/","title":{"rendered":"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)"},"content":{"rendered":"\n<p>D\u00e9sol\u00e9, cet article est seulement disponible en\u00a0<a href=\"https:\/\/innovativemedicines.ca\/en\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\">Anglais Am\u00e9ricain<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00e9sol\u00e9, cet article est seulement disponible en\u00a0Anglais Am\u00e9ricain.<\/p>\n","protected":false},"featured_media":14030,"template":"","topic":[244],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-14482","news","type-news","status-publish","has-post-thumbnail","hentry","topic-propriete-intellectuelle","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"D\u00e9sol\u00e9, cet article est seulement disponible en\u00a0Anglais Am\u00e9ricain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-30T21:58:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\",\"name\":\"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg\",\"datePublished\":\"2022-06-10T21:55:00+00:00\",\"dateModified\":\"2022-06-30T21:58:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage\",\"url\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg\",\"contentUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/","og_locale":"fr_FR","og_type":"article","og_title":"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada","og_description":"D\u00e9sol\u00e9, cet article est seulement disponible en\u00a0Anglais Am\u00e9ricain.","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2022-06-30T21:58:08+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/","name":"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12) - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg","datePublished":"2022-06-10T21:55:00+00:00","dateModified":"2022-06-30T21:58:08+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/sponsorship-application-hero.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/"},{"@type":"ListItem","position":4,"name":"Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/14482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/14030"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=14482"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=14482"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=14482"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=14482"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=14482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}